These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3588783)

  • 1. A family study of plasma dopamine-beta-hydroxylase in schizophrenia.
    Sakellariou G; Markianos M; Tsichlakis N; Kartakis D
    Psychiatry Res; 1987 Mar; 20(3):221-7. PubMed ID: 3588783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma dopamine beta-hydroxylase activity in a North Swedish isolate with a high frequency of schizophrenia.
    Ross SB; Böök JA; Wetterberg L
    Clin Genet; 1981 May; 19(5):415-7. PubMed ID: 7296932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma DBH activity: relation to genetic factors in schizophrenia.
    Baron M; Levitt M; Perlman R
    Commun Psychopharmacol; 1980; 4(3):197-202. PubMed ID: 7226750
    [No Abstract]   [Full Text] [Related]  

  • 5. No association between a putative functional promoter variant in the dopamine beta-hydroxylase gene and schizophrenia.
    Jönsson EG; Abou Jamra R; Schumacher J; Flyckt L; Edman G; Forslund K; Mattila-Evenden M; Rylander G; Asberg M; Bjerkenstedt L; Wiesel FA; Propping P; Cichon S; Nöthen MM; Sedvall GC
    Psychiatr Genet; 2003 Sep; 13(3):175-8. PubMed ID: 12960750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between the DBH gene, plasma dopamine β-hydroxylase activity and cognitive measures in Han Chinese patients with schizophrenia.
    Sun Z; Ma Y; Li W; He J; Li J; Yang X; Mao P; Cubells JF; Tang YL
    Schizophr Res; 2018 Mar; 193():58-63. PubMed ID: 28647493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
    Xavier Vieira R; Azevedo M; Polónio P; Manso C
    Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-beta-hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients.
    Yu PH; O'Sullivan KS; Keegan D; Boulton AA
    Psychiatry Res; 1980 Oct; 3(2):205-10. PubMed ID: 6947313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum dopamine-beta-hydroxylase in schizophrenic patients.
    Fujita K; Ito T; Maruta K; Teradaira R; Beppu H; Nakagami Y; Kato Y; Nagatsu T; Kato T
    J Neurochem; 1978 Jun; 30(6):1569-72. PubMed ID: 670998
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
    Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O
    Encephale; 1981; 7(1):95-103. PubMed ID: 7227288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
    Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers.
    Zhang XY; Chen DC; Xiu MH; Hui L; Liu H; Luo X; Zuo L; Zhang H; Kosten TA; Kosten TR
    Schizophr Res; 2012 Oct; 141(1):48-53. PubMed ID: 22871345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic study of plasma dopamine beta hydroxylase activity in man.
    Mendlewicz J; Levitt M; Fleiss JL
    Acta Genet Med Gemellol (Roma); 1975; 24(1-2):105-10. PubMed ID: 1241486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma dopamine beta-hydroxylase activity in clinically healthy children].
    Mello P; Stagni S; Gualandi S; Illuminati B; Guidi M; Corsini F
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1597-602. PubMed ID: 7459080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme studies in tardive dyskinesia. II. Familial aspects.
    Delisi LE; Jeste DV; Phelps BH; Wyatt RJ
    J Clin Psychopharmacol; 1982 Oct; 2(5):315-7. PubMed ID: 7130433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MAO, D beta H, and COMT activities in chronic schizophrenics selected on the basis of nailfold capillary pattern.
    Dunlop SR; Sattin A; Shea P; Hendrie HC
    Acta Psychiatr Scand; 1981 Nov; 64(5):409-14. PubMed ID: 7347105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia.
    Castellani S; Ziegler MG; van Kammen DP; Alexander PE; Siris SG; Lake CR
    Arch Gen Psychiatry; 1982 Oct; 39(10):1145-9. PubMed ID: 7125844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
    Markianos M; Tripodianakis J; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.